Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) saw some unusual options trading activity on Tuesday. Traders acquired 24,073 call options on the stock. This represents an increase of approximately 38% compared to the typical volume of 17,462 call options.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Friday, February 9th.
Check Out Our Latest Analysis on ACB
Aurora Cannabis Stock Performance
Aurora Cannabis (NASDAQ:ACB – Get Free Report) last announced its earnings results on Thursday, February 8th. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.10). Aurora Cannabis had a negative return on equity of 23.27% and a negative net margin of 48.82%. The firm had revenue of $53.34 million during the quarter, compared to analyst estimates of $45.94 million. Analysts forecast that Aurora Cannabis will post -0.85 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in ACB. MMCAP International Inc. SPC bought a new stake in Aurora Cannabis in the 3rd quarter valued at $4,659,000. Mirae Asset Global Investments Co. Ltd. increased its holdings in Aurora Cannabis by 6.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,888,202 shares of the company’s stock valued at $1,690,000 after buying an additional 172,049 shares during the period. Yong Rong HK Asset Management Ltd bought a new stake in Aurora Cannabis in the 3rd quarter valued at $878,000. Cambria Investment Management L.P. increased its holdings in Aurora Cannabis by 115.5% in the 3rd quarter. Cambria Investment Management L.P. now owns 386,365 shares of the company’s stock valued at $226,000 after buying an additional 207,095 shares during the period. Finally, Mackenzie Financial Corp acquired a new stake in shares of Aurora Cannabis in the 4th quarter valued at $98,000. 47.63% of the stock is currently owned by institutional investors and hedge funds.
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Articles
- Five stocks we like better than Aurora Cannabis
- What is the FTSE 100 index?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- 5 Top Rated Dividend Stocks to Consider
- Lockheed Martin Stock Aims for a Fresh All-Time High
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.